Cite
HARVARD Citation
Gengiah, T. et al. (2022). CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ open. 12 (1), p. . [Online].